The clinical data from the previous study should be extensively confirmed, since part of their conclusions are not consistent with our and other studies, including the negative expression of CD11b and CD11c in APL patients and the expression of CD64 in only some of the APL patients. This evidence concerns the gene ITGAX and acute promyelocytic leukemia.